Shareholders approve Ottawa-based Tetra Bio-Pharma’s $12M acquisition
Tetra Bio-Pharma’s shareholders are endorsing the local firm’s plans to accelerate its cannabidiol research efforts as excitement around the market for hemp-based products heats up.